Search - tctmd.com

Displaying 121 - 140 of 586

Sort: Relevancy | Date

News Daily News

AHA Updates Its Scientific Statement on CIED Infections

Todd Neale

December 11, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2023

Shelley Wood

November 30, 2023

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

L.A. McKeown

November 20, 2023

News Conference News AHA 2023

Sudden Cardiac Death Declining Among NCAA Athletes

Michael O'Riordan

November 15, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Daily News

AHA Throws Its Support Behind New, Independent Medical Board

Michael O'Riordan

October 30, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Conference News EACTS 2023

Combined Surgical and Catheter Ablation Best for Persistent AF

Michael O'Riordan

October 12, 2023

News Daily News

Cardiology Society Leaders Expand on Vision for New Medical Board

Todd Neale

October 05, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

News Daily News

One-Third of Patients With AF After Surgery or Illness Have Recurrences

Michael O'Riordan

October 02, 2023

News Daily News

Home-Based Care: ACC Workbook Aims to Inspire

Caitlin E. Cox

October 02, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

News Daily News

‘Astonishing’ Rates of CVD Linked to Lead Exposure

Caitlin E. Cox

September 13, 2023

News Daily News

Nonwhite Cardiac Arrest Victims Are More Likely to Die Prehospital: Why?

L.A. McKeown

September 11, 2023

News Daily News

Hospital at Home Strategy Could Disrupt ‘Low-Value’ Care for Worsening HF

L.A. McKeown

September 07, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

Advertisement

AHA Updates Its Scientific Statement on CIED Infections

TCTMD’s Top 10 Most Popular Stories for November 2023

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

Sudden Cardiac Death Declining Among NCAA Athletes

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

What’s Going to Be Hot at AHA 2023

TCTMD’s Top 10 Most Popular Stories for October 2023

AHA Throws Its Support Behind New, Independent Medical Board

What’s Going to Be Hot at TCT 2023

Combined Surgical and Catheter Ablation Best for Persistent AF

Cardiology Society Leaders Expand on Vision for New Medical Board

TCTMD’s Top 10 Most Popular Stories for September 2023

One-Third of Patients With AF After Surgery or Illness Have Recurrences

Home-Based Care: ACC Workbook Aims to Inspire

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

‘Astonishing’ Rates of CVD Linked to Lead Exposure

Nonwhite Cardiac Arrest Victims Are More Likely to Die Prehospital: Why?

Hospital at Home Strategy Could Disrupt ‘Low-Value’ Care for Worsening HF

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content